Treatment of epilepsy in adults: Expert opinion, 2005

Epilepsy and Behavior

Volumn 7, Issue SUPPL. 1, 2005, Pages 1-64

  Karceski, Steven ^a   Morrell, Martha J ^b   Carpenter, Daniel ^c  

^a College of Physicians and Surgeons ^*  (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c Univ S Carolina Sch Med Vice P   (United States)

Author keywords

Antiepileptic drugs; Depression; Driving; Epilepsy; Expert consensus; HIV; Idiopathic generalized epilepsy; Pregnancy; Seizures; Symptomatic localization related epilepsy

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; MESUXIMIDE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABSENCE; ADOLESCENT; ADULT; COMORBIDITY; COMPLEX PARTIAL SEIZURE; CONSENSUS; DATA ANALYSIS; DEPRESSION; DISEASE SIMULATION; DRUG CHOICE; EPILEPSY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KETOGENIC DIET; KIDNEY DISEASE; LIVER DISEASE; MEDICAL EXPERT; MONOTHERAPY; MYOCLONUS SEIZURE; PREGNANT WOMAN; QUESTIONNAIRE; REVIEW; STATISTICAL ANALYSIS; TONIC CLONIC SEIZURE; UNITED STATES;

EID: 23644441735     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2005.06.001     Document Type: Article

References (75)

1. K.L. Goa S.R. Ross P. Chrisp Lamotrigine: A review of its pharmacological properties and clinical efficacy in epilepsy Drugs 46 1993 152-176
2. H. Anhut P. Ashman T.J. Feuerstein W. Sauermann M. Saunders B. Schmidt Gabapentin as add-on therapy in patients with partial seizures: A double-blind placebo-controlled study Epilepsia 35 1994 795-801
3. US Gabapentin Study Group. Gabapentin as add-on therapy in refractory epilepsy: A double-blind, placebo-controlled, parallel-group study. Neurology 1993;43:2292-8.
4. L. Gram Oxcarbazepine in: J. Engel Jr. T.A. Pedley editors Epilepsy: A comprehensive textbook 1997 Lippincott-Raven Philadelphia 1541-1546
5. L.D. Kramer R.A. Reife Topiramate in: J. Engel Jr. T.A. Pedley editros Epilepsy: A comprehensive textbook 1997 Lippincott-Raven Philadelphia 1593-1598
6. Sachdeo RC, Leroy RF, Krauss GL, et al. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group. Arch Neurol 1997;54:595-601.
7. W.H. Theodore Felbamate in: J. Engel Jr. T.A. Pedley editors Epilepsy: A comprehensive textbook 1997 Lippincott-Raven Philadelphia 1509-1514
8. J.J. Cereghino V. Biton B. Abou-Khalil F. Dreifuss L.J. Gauer I. Leppik Levetiracetam for partial seizures: Results of a double-blind randomized clinical trial Neurology 55 2000 236-242
9. H.S. White Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs Epilepsia 40 Suppl. 5 1999 S2-S10
10. J.W. Wheless V. Venkataraman New formulations of drugs in epilepsy Expert Opin Pharmacother 1 1999 49-60
11. B.J. Wilder Vagal nerve stimulation in: J. Engel Jr. T.A. Pedley editors Epilepsy: A comprehensive textbook 1997 Lippincott-Raven Philadelphia 1353-1358
12. E.P.G. Vining Ketogenic diet in; J. Engel Jr. T.A. Pedley editors Epilepsy: A comprehensive textbook 1997 Lippincott-Raven Philadelphia 1334-1344
13. H. Shmizu J. Kawasaki S. Yuasa Y. Tarao S. Kumagai K. Kanemoto Use of clobazam for the treatment of refractory complex partial seizures Seizure 12 2003 282-286
14. M.J. Brodie Management strategies for localization-related seizures Epilepsia 42 Suppl. 3 2001 27-30
15. Montenegro MA, Cendes F, Noronha AL, et al. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy. Epilepsia 2001;42:539-42.
16. E.A. Thiele Managing epilepsy in tuberous sclerosis J Child Neurol 19 2004 680-686
17. S. Wiebe W.T. Blume J.P. Girvin M. Eliasziw Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized controlled trial of surgery for temporal lobe epilepsy N Engl J Med 345 2001 311-318
18. S. Wiebe Early epilepsy surgery Curr Neurol Neurosci Rep 4 2004 315-320
19. Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA; Pregabalin 1008-009 Study Group. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005;64:475-80.
20. Arroyo S. Anhut H. Kugler A.R. Lee C.M. Knapp L.E. Garofalo E.A. Messmer S. Pregabalin 1008-011 International Study Group. Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004;45:20-7.
21. J.A. French A.R. Kugler J.L. Robbins L.E. Knapp E.A. Garofalo Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures Neurology 60 2003 1631-1637
22. M.D. Privitera Evidence-based medicine and antiepileptic drugs Epilepsia 40 Suppl. 5 1999 S47-S56
23. P.R. Williamson A.G. Marson C. Tudur J.L. Hutton D. Chadwick Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials J Eval Clin Pract 6 2000 205-214
24. S. Karceski M. Morrell D. Carpenter The expert consensus guideline series: Treatment of epilepsy Epilepsy Behav 2 Suppl. 2001 A1-A50
25. D.A. Kahn J.P. Docherty D. Carpenter A. Frances Consensus methods in practice guideline development: A review and description of a new method Psychpharmacol Bull 33 1997 631-639
26. Dalkey NC. The Delphi method: An experimental study of group opinion. Santa Monica, CA: RAND Corp.; 1969. Publication # RM-58888 PR.
27. S.H. Woolfe Practice guidelines, a new reality in medicine Arch Intern Med 152 1992 946-952
28. R.H. Brook M.R. Chassin A. Fink D.H. Solomon J. Kosecoff R.E. Park A method for the detailed assessment of the appropriateness of medical technologies Int J Tech Assess Health Care 2 1986 53-63
29. A. Frances D. Kahn D. Carpenter C. Frances J. Docherty A new method of developing expert consensus practice guidelines Am J Manag Care 4 1998 1023-1029
30. D.A. Kahn D. Carpenter J.P. Docherty A. Frances The expert consensus guideline series: Treatment of bipolar disorder J Clin Psychiatry 57 Suppl. 12a 1996 1-88
31. J.P. McEvoy P.J. Weiden T.E. Smith D. Carpenter D.A. Kahn A. Frances The expert consensus guideline series: Treatment of schizophrenia J Clin Psychiatry 57 Suppl. 12b 1996 1-58
32. J.S. March A. Frances D. Carpenter D.A. Kahn The expert consensus guideline series: Treatment of obsessive-compulsive disorder J Clin Psychiatry 58 Suppl. 4 1997 1-72
33. Alexopoulos GS, Silver JM, Kahn DA, Frances A, Carpenter D. The expert consensus guideline series: Treatment of agitation in older persons with dementia. Postgrad Med Special Report 1998;April:1-88.
34. J.P. McEvoy P.L. Scheifler A. Frances The expert consensus guideline series: Treatment of schizophrenia 1999 J Clin Psychiatry 60 Suppl. 11 1999 1-80
35. E.B. Foa J.R.T. Davidson A. Frances The expert consensus guideline series: Treatment of posttraumatic stress disorder J Clin Psychiatry 60 Suppl. 16 1999 1-76
36. A.J. Rush A. Frances Expert consensus guideline series: Treatment of psychiatric and behavioral problems in mental retardation Am J Mental Retardation 105 2000 159-228
37. Sachs GS, Printz DJ, Kahn DA, Carpenter D. The expert consensus guideline series: Medication treatment of bipolar disorder 2000. Postgrad Med Special Report 2000;Apr;1-104.
38. Altshuler LL, Cohen LS, Moline ML, Kahn DA, Carpenter D, Docherty JP. The expert consensus guideline series: Treatment of depression in women 2001. Postgrad Med Special Report 2001;March:1-115.
39. C.K. Conners J.S. March A. Frances K.C. Wells R. Ross Expert consensus guideline series: Treatment of attention-deficit/hyperactivity disorder J Atten Disord 4 Suppl. 1 2001 S1-S128
40. Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP. The expert consensus guideline series: Treatment of behavioral emergencies. Postgrad Med Special Report 2001;May:1-88.
41. Alexopoulos GS, Katz IR, Reynolds CF, Carpenter D, Docherty JP. The expert consensus guideline series: Treatment of depressive disorders in older patients. Postgrad Med Special Report 2001;October:1-86.
42. J.M. Kane S. Leucht D. Carpenter J.P. Docherty Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders J Clin Psychiatry 63 Suppl. 12 2003 5-19
43. G.S. Alexopulos J. Streim D. Carpenter J.P. Docherty The expert consensus guideline series: Using antipsychotic agents in older patients J Clin Psychiatry 65 Suppl. 2 2004 1-105
44. Keck PE, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: Treatment of bipolar disorder 2004. Postgrad Med Special Report 2004;December:1-120.
45. Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: Treatment of dementia and its behavioral disturbances. Postgrad Med Special Report 2005;January:1-111.
46. S. Sato F.E. Dreifuss J.K. Penry Prognostic factors in absence seizures Neurology 26 1976 788-796
47. L.D. Morton J.M. Pellock Diagnosis and treatment of epilepsy in childhood and adolescents Drugs 51 1996 399-414
48. J.M. Freeman J. Tibbles C. Camfield P. Camfield Benign epilepsy of childhood: A speculation and its ramifications Pediatrics 79 1987 864-868
49. French J.A. Kanner A.M. Bautista J. et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Neurology 2004;62:1252-60.
50. French J.A. Kanner A.M. Bautista J. et al. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Neurology 2004;62:1261-73.
51. R. Guerrini C. Dravet P. Genton A. Belmonte A. Kaminska O. Dulac Lamotrigine and seizure aggravation in severe myoclonic epilepsy Epilepsia 39 1998 508-512
52. Carrazana EJ, Wheeler SD. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2001;22;56:1424-5.
53. G.L. Morris A.E. Hammer R.P. Kustra J.A. Messenheimer Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: Results of an open-label study Epilepsy Behav 5 2004 509-512
54. Mattson R.H. Cramer J.A. Collins J.F. et al. Comparison of carbamazepine phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51.
55. R.H. Mattson J.A. Cramer J.F. Collins Comparison of valproate and carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic-seizures in adults N Engl J Med 327 1992 765-771
56. Deckers C.L. Czuczwar S.J. Hekster Y.A. et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: The evidence reviewed. Epilepsia 2000;41:1364-74.
57. Genton P. Bauer J. Duncan S. et al. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001;42:295-304.
58. J.I. Isojarvi T.J. Laatikainen M. Knip A.J. Pakarinen K.T. Juntunen V.V. Myllyla Obesity and endocrine disorders in women taking valproate for epilepsy Ann Neurol 39 1996 579-584
59. Isojarvi J.I. Rattya J. Myllyla V.V. et al. Valproate lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-51.
60. M.J. Morrell Effects of epilepsy on women's reproductive health Epilepsia 39 Suppl. 8 1998 S32-S37
61. Morrell MJ, Giudice L, Flynn KL, Seale CG, Paulson AJ, Done S, Flaster E, Ferin M, Sauer MV. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002;52:704-11.
62. J.I. Sirven Acute and chronic seizures in patients older than 60 years Mayo Clin Proc 76 2001 175-183
63. L.J. Willmore Choice of newer anticonvulsant drugs in older patients Drugs Aging 17 2000 441-452
64. R.E. Ramsay F. Pryor Epilepsy in the elderly Neurology 55 Suppl. 1 2000 S9-S14
65. K.J. Meador Current discoveries on the cognitive effects of antiepileptic drugs Pharmacotherapy 20 8 Pt. 2 2000 185S-190S
66. P. Mullin G. Green R. Bakshi Special populations: The management of seizures in HIV-positive patients Curr Neurol Neurosci Rep 4 2004 308-314
67. Goodwin G.M. Bowden C.L. Calabrese J.R. et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432-41.
68. Calabrese J.R. Bowden C.L. Sachs G. et al. Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-24.
69. M.R. Trimble Neuropsychiatric consequences of pharmacotherapy in: J. Engel Jr. T.A. Pedley editors Epilepsy: A comprehensive textbook 1997 Lippincott-Raven Philadelphia 2161-2170
70. P. Kwan M.J. Brodie Neuropsychological effects of epilepsy and antiepileptic drugs Lancet 357 2001 216-222
71. T.A. Mellman A.L. Miller E.M. Weissman M.L. Crismon S.M. Essock S.R. Marder Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms Psychiatr Serv 52 2001 619-625
72. S.G. Sheth G. Krauss A. Krumholz G. Li Mortality in epilepsy: Driving fatalities vs other causes of death in patients with epilepsy Neurology 63 2004 1002-1007
73. A. Black S.F. Berkovic New driving guidelines: Ethical and legal uncertainties Med J Aust 179 2003 327-328
74. Drazkowski J.F. Fisher R.S. Sirven J.I. et al. Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc 2003;78:819-25.
75. D.W. Chadwick Driving restrictions and people with epilepsy Neurology 57 2001 1749-1750